HEART FAILURE
Remote monitoring of heart failure patients
The challenge in Heart Failure monitoring
Remote patient monitoring (RPM) plays a critical role in managing heart failure to prevent hospitalizations. Traditional methods—such as checking symptoms and tracking weight or blood pressure through phone calls or clinic visits—have important limitations. By the time noticeable symptoms appear, the condition may already have worsened to the point where hospitalization is difficult to prevent.
RPM using intravascular devices has shown potential to reduce rehospitalizations. However, they still miss over 60% of rehospitalizations and 75% of deaths. These platforms measure only one parameter of this highly complex condition, preventing a deep understanding of the reason for the decompensation and hindering appropriate medication adjustments. Furthermore, the monitoring method they propose places a heavy operational burden on clinicians, requiring them to manually analyse data, conduct patient follow-ups, and adjust medication protocols.
Our solution: a multiparametric sensing platform for physician-directed patients self-management
At FORESEE we are developing a novel multiparametric intravascular microsensor that provides precise and trustworthy data to back a safe physician-directed patients self-management approach. It is based in an innovative powering and communication technology that avoids the use of bulky components within the implant.
The FORESEE platform is composed of:
- a wireless multiparametric Intravascular microsensor,
- an External unit that wirelessly powers and communicates with it,
- a Delivery system to deploy the Intravascular microsensor in a branch of the pulmonary artery, and
- an Application to visualize the parameters obtained from each patient, trigger alarms and aid in the monitoring and control of patients.
How it works
1. Each morning, patients will take a single 5-minute measurement from home.
2. The data will be sent to clinicians and alerts will trigger if early signs of decompensation are detected.
3. Clinicians will confidently empower patients with targeted, real-time treatment adjustments for proactive daily care.
